Patent Ductus Arteriosus in Preterm Infants

被引：252
|
作者：
Benitz, William E.
机构：
来源：
PEDIATRICS | 2016年 / 137卷 / 01期
关键词：
BIRTH-WEIGHT INFANTS; RESPIRATORY-DISTRESS SYNDROME; PREMATURE-INFANTS; INDOMETHACIN PROPHYLAXIS; SURGICAL CLOSURE; CONTROLLED-TRIAL; RISK-FACTORS; BLOOD-FLOW; 1000; GRAMS; LIGATION;
D O I：
10.1542/peds.2015-3730
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Despite a large body of basic science and clinical research and clinical experience with thousands of infants over nearly 6 decades, 1 there is still uncertainty and controversy about the significance, evaluation, and management of patent ductus arteriosus in preterm infants, resulting in substantial heterogeneity in clinical practice. The purpose of this clinical report is to summarize the evidence available to guide evaluation and treatment of preterm infants with prolonged ductal patency in the first few weeks after birth.
引用
收藏
页数：6
相关论文
共 50 条
  • [21] Paracetamol treatment of patent ductus arteriosus in preterm infants
    E Nadir
    E Kassem
    S Foldi
    A Hochberg
    M Feldman
    Journal of Perinatology, 2014, 34 : 748 - 749
  • [22] Echocardiographic Evaluation of Patent Ductus Arteriosus in Preterm Infants`
    Arlettaz, Romaine
    FRONTIERS IN PEDIATRICS, 2017, 5
  • [23] Paracetamol in treatment of patent ductus arteriosus in preterm infants
    Shah, Amit P.
    INDIAN PEDIATRICS, 2014, 51 (07) : 590 - 590
  • [24] Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants
    De Carolis, MP
    Romagnoli, C
    Polimeni, V
    Piersigilli, F
    Zecca, E
    Papacci, P
    Delogu, AB
    Tortorolo, G
    EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (05) : 364 - 368
  • [25] Determination of Genetic Predisposition to Patent Ductus Arteriosus in Preterm Infants
    Dagle, John M.
    Lepp, Nathan T.
    Cooper, Margaret E.
    Schaa, Kendra L.
    Kelsey, Keegan J. P.
    Orr, Kristin L.
    Caprau, Diana
    Zimmerman, Cara R.
    Steffen, Katherine M.
    Johnson, Karen J.
    Marazita, Mary L.
    Murray, Jeffrey C.
    PEDIATRICS, 2009, 123 (04) : 1116 - 1123
  • [26] Current controversies in the management of patent ductus arteriosus in preterm infants
    Ibrahim, Thowfique K.
    Haium, A. A. Abdul
    Chandran, S.
    Rajadurai, V. S.
    INDIAN PEDIATRICS, 2014, 51 (04) : 289 - 294
  • [27] Natriuretic peptides as markers of patent ductus arteriosus in preterm infants
    Holmstrom, H
    Omland, T
    CLINICAL SCIENCE, 2002, 103 (01) : 79 - 80
  • [28] Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus
    Struis, N
    Andriessen, P
    Van Overmeire, B
    PEDIATRIC RESEARCH, 2003, 53 (04) : 508A - 508A
  • [29] Neonatal AKI in late preterm infants with patent ductus arteriosus
    Yurttutan, Sadik
    Gullu, Utku Ufuk
    JOURNAL OF PERINATOLOGY, 2021, 41 (10) : 2383 - 2384
  • [30] Furosemide in preterm infants treated with indomethacin for patent ductus arteriosus
    Andriessen, Peter
    Struis, Nicole C.
    Niemarkt, Hendrik
    Oetomo, Sidarto Bambang
    Tanke, Ronald B.
    Van Overmeire, Bart
    ACTA PAEDIATRICA, 2009, 98 (05) : 797 - 803
12345